<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>EMA Medicine Updates</title>
    <link>https://www.ema.europa.eu/en/medicines</link>
    <description><![CDATA[Monitored updates for specific medicines from the European Medicines Agency.]]></description>
    <lastBuildDate>Fri, 06 Feb 2026 12:30:00 -0000</lastBuildDate>
    <atom:link href="https://igoraj.github.io/feedr/ema_updates.xml" rel="self" type="application/rss+xml"/>
    <item>
      <title>Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 19, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 19, Status: Authorised]]></description>
      <pubDate>Fri, 06 Feb 2026 12:30:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 14, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/wegovy</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/wegovy</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 14, Status: Authorised]]></description>
      <pubDate>Thu, 05 Feb 2026 12:57:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Status: Opinion</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/kayshild</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/kayshild</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Kayshild, semaglutide, Status: Opinion]]></description>
      <pubDate>Fri, 30 Jan 2026 11:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 17, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/rybelsus</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/rybelsus</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Date of authorisation: 03/04/2020, Revision: 17, Status: Authorised]]></description>
      <pubDate>Tue, 27 Jan 2026 15:25:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 19, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 19, Status: Authorised]]></description>
      <pubDate>Tue, 27 Jan 2026 15:24:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Dapagliflozin Viatris, dapagliflozin, Date of authorisation: 24/03/2023, Revision: 5, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/dapagliflozin-viatris</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/dapagliflozin-viatris</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Dapagliflozin Viatris, dapagliflozin, Date of authorisation: 24/03/2023, Revision: 5, Status: Authorised]]></description>
      <pubDate>Mon, 26 Jan 2026 13:10:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Victoza, liraglutide, Date of authorisation: 30/06/2009, Revision: 25, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/victoza</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/victoza</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Victoza, liraglutide, Date of authorisation: 30/06/2009, Revision: 25, Status: Authorised]]></description>
      <pubDate>Fri, 16 Jan 2026 12:55:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Otezla, apremilast, Date of authorisation: 15/01/2015, Revision: 25, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/otezla</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/otezla</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Otezla, apremilast, Date of authorisation: 15/01/2015, Revision: 25, Status: Authorised]]></description>
      <pubDate>Wed, 14 Jan 2026 15:15:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/apremilast-accord</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/apremilast-accord</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised]]></description>
      <pubDate>Wed, 07 Jan 2026 13:38:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Jalra, vildagliptin, Date of authorisation: 19/11/2008, Revision: 26, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/jalra</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/jalra</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Jalra, vildagliptin, Date of authorisation: 19/11/2008, Revision: 26, Status: Authorised]]></description>
      <pubDate>Mon, 05 Jan 2026 16:45:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 25, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/xiliarx</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/xiliarx</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Xiliarx, vildagliptin, Date of authorisation: 19/11/2008, Revision: 25, Status: Authorised]]></description>
      <pubDate>Mon, 05 Jan 2026 15:30:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 24, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/jentadueto</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/jentadueto</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 24, Status: Authorised]]></description>
      <pubDate>Thu, 18 Dec 2025 14:15:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 24, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/jentadueto</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/jentadueto</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 24, Status: Authorised]]></description>
      <pubDate>Thu, 18 Dec 2025 14:15:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/qtern</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/qtern</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Qtern, saxagliptin,dapagliflozin, Date of authorisation: 15/07/2016, Revision: 14, Status: Authorised]]></description>
      <pubDate>Thu, 18 Dec 2025 12:02:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/xigduo</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/xigduo</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised]]></description>
      <pubDate>Thu, 18 Dec 2025 12:01:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/xigduo</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/xigduo</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 25, Status: Authorised]]></description>
      <pubDate>Thu, 18 Dec 2025 12:01:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ebymect</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/ebymect</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ebymect</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/ebymect</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 27, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/invokana</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/invokana</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 27, Status: Authorised]]></description>
      <pubDate>Thu, 18 Dec 2025 09:46:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 27, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/eucreas</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/eucreas</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 27, Status: Authorised]]></description>
      <pubDate>Mon, 08 Dec 2025 10:32:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 27, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/eucreas</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/eucreas</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Eucreas, vildagliptin,metformin, Date of authorisation: 14/11/2007, Revision: 27, Status: Authorised]]></description>
      <pubDate>Mon, 08 Dec 2025 10:32:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/icandra</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/icandra</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised]]></description>
      <pubDate>Fri, 05 Dec 2025 14:45:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/icandra</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/icandra</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised]]></description>
      <pubDate>Fri, 05 Dec 2025 14:45:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/zomarist</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/zomarist</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised]]></description>
      <pubDate>Fri, 05 Dec 2025 14:35:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/zomarist</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/zomarist</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised]]></description>
      <pubDate>Fri, 05 Dec 2025 14:35:00 -0000</pubDate>
    </item>
    <item>
      <title>Xelevia : EPAR - Procedural steps taken and scientific information after authorisation (archive)</title>
      <link>https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0762-steps-after_en_0.pdf</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0762-steps-after_en_0.pdf</guid>
      <description><![CDATA[Xelevia : EPAR - Procedural steps taken and scientific information after authorisation (archive)]]></description>
      <pubDate>Mon, 01 Dec 2025 16:33:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation: 16/07/2008, Revision: 40, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/velmetia</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/velmetia</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation: 16/07/2008, Revision: 40, Status: Authorised]]></description>
      <pubDate>Mon, 01 Dec 2025 15:44:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation: 16/07/2008, Revision: 40, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/velmetia</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/velmetia</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Velmetia, sitagliptin,metformin, Date of authorisation: 16/07/2008, Revision: 40, Status: Authorised]]></description>
      <pubDate>Mon, 01 Dec 2025 15:44:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 37, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/efficib</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/efficib</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 37, Status: Authorised]]></description>
      <pubDate>Mon, 01 Dec 2025 13:10:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 37, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/efficib</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/efficib</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 37, Status: Authorised]]></description>
      <pubDate>Mon, 01 Dec 2025 13:10:00 -0000</pubDate>
    </item>
    <item>
      <title>Tesavel : EPAR - Procedural steps taken and scientific information after authorisation (archive)</title>
      <link>https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0910-steps_after_en_0.pdf</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0910-steps_after_en_0.pdf</guid>
      <description><![CDATA[Tesavel : EPAR - Procedural steps taken and scientific information after authorisation (archive)]]></description>
      <pubDate>Mon, 01 Dec 2025 11:08:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Date of authorisation: 23/03/2018, Revision: 14, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/steglujan</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/steglujan</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Steglujan, ertugliflozin,sitagliptin, Date of authorisation: 23/03/2018, Revision: 14, Status: Authorised]]></description>
      <pubDate>Fri, 21 Nov 2025 14:58:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Segluromet, ertugliflozin,metformin hydrochloride, Date of authorisation: 23/03/2018, Revision: 10, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/segluromet</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/segluromet</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Segluromet, ertugliflozin,metformin hydrochloride, Date of authorisation: 23/03/2018, Revision: 10, Status: Authorised]]></description>
      <pubDate>Fri, 21 Nov 2025 14:46:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 32, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/synjardy</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/synjardy</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 32, Status: Authorised]]></description>
      <pubDate>Wed, 19 Nov 2025 11:50:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 32, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/synjardy</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/synjardy</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 32, Status: Authorised]]></description>
      <pubDate>Wed, 19 Nov 2025 11:50:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 31, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ristfor</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/ristfor</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 31, Status: Authorised]]></description>
      <pubDate>Mon, 17 Nov 2025 16:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 31, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ristfor</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/ristfor</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Date of authorisation: 15/03/2010, Revision: 31, Status: Authorised]]></description>
      <pubDate>Mon, 17 Nov 2025 16:00:00 -0000</pubDate>
    </item>
    <item>
      <title>Sitagliptin / Metformin hydrochloride Accord : EPAR - Product information</title>
      <link>https://www.ema.europa.eu/system/files/documents/product-information/sitagliptin-metformin-hydrochloride-accord-epar-product-information_en.pdf</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/system/files/documents/product-information/sitagliptin-metformin-hydrochloride-accord-epar-product-information_en.pdf</guid>
      <description><![CDATA[Sitagliptin / Metformin hydrochloride Accord : EPAR - Product information]]></description>
      <pubDate>Thu, 13 Nov 2025 14:04:00 -0000</pubDate>
    </item>
    <item>
      <title>Sitagliptin / Metformin hydrochloride Accord : EPAR - Product information</title>
      <link>https://www.ema.europa.eu/system/files/documents/product-information/sitagliptin-metformin-hydrochloride-accord-epar-product-information_en.pdf</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/system/files/documents/product-information/sitagliptin-metformin-hydrochloride-accord-epar-product-information_en.pdf</guid>
      <description><![CDATA[Sitagliptin / Metformin hydrochloride Accord : EPAR - Product information]]></description>
      <pubDate>Thu, 13 Nov 2025 14:04:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Janumet, sitagliptin,metformin, Date of authorisation: 16/07/2008, Date of refusal: 18/02/2009, Revision: 34, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/janumet</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/janumet</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Janumet, sitagliptin,metformin, Date of authorisation: 16/07/2008, Date of refusal: 18/02/2009, Revision: 34, Status: Authorised]]></description>
      <pubDate>Thu, 13 Nov 2025 08:20:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Janumet, sitagliptin,metformin, Date of authorisation: 16/07/2008, Date of refusal: 18/02/2009, Revision: 34, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/janumet</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/janumet</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Janumet, sitagliptin,metformin, Date of authorisation: 16/07/2008, Date of refusal: 18/02/2009, Revision: 34, Status: Authorised]]></description>
      <pubDate>Thu, 13 Nov 2025 08:20:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 3, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-sun</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-sun</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitagliptin fumarate, Date of authorisation: 09/12/2021, Revision: 3, Status: Authorised]]></description>
      <pubDate>Mon, 10 Nov 2025 15:50:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 35, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/januvia</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/januvia</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Januvia, sitagliptin, Date of authorisation: 20/03/2007, Revision: 35, Status: Authorised]]></description>
      <pubDate>Fri, 31 Oct 2025 10:13:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 30, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/ristaben</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/ristaben</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 30, Status: Authorised]]></description>
      <pubDate>Thu, 30 Oct 2025 15:36:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-mylan</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-mylan</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised]]></description>
      <pubDate>Tue, 30 Sep 2025 13:27:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-mylan</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-mylan</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised]]></description>
      <pubDate>Tue, 30 Sep 2025 13:27:00 -0000</pubDate>
    </item>
    <item>
      <title>Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Status: Opinion</title>
      <link>https://www.ema.europa.eu/en/medicines/human/EPAR/kyinsu</link>
      <guid isPermaLink="true">https://www.ema.europa.eu/en/medicines/human/EPAR/kyinsu</guid>
      <description><![CDATA[Human medicines European public assessment report (EPAR): Kyinsu, insulin icodec,semaglutide, Status: Opinion]]></description>
      <pubDate>Fri, 19 Sep 2025 10:00:00 -0000</pubDate>
    </item>
  </channel>
</rss>
